The cellular prion protein traps Alzheimer's Aß in an oligomeric form and disassembles amyloid fibers.
FASEB J
; 27(5): 1847-58, 2013 May.
Article
em En
| MEDLINE
| ID: mdl-23335053
ABSTRACT
There is now strong evidence to show that the presence of the cellular prion protein (PrP(C)) mediates amyloid-ß (Aß) neurotoxicity in Alzheimer's disease (AD). Here, we probe the molecular details of the interaction between PrP(C) and Aß and discover that substoichiometric amounts of PrP(C), as little as 1/20, relative to Aß will strongly inhibit amyloid fibril formation. This effect is specific to the unstructured N-terminal domain of PrP(C). Electron microscopy indicates PrP(C) is able to trap Aß in an oligomeric form. Unlike fibers, this oligomeric Aß contains antiparallel ß sheet and binds to a oligomer specific conformational antibody. Our NMR studies show that a specific region of PrP(C), notably residues 95-113, binds to Aß oligomers, but only once Aß misfolds. The ability of PrP(C) to trap and concentrate Aß in an oligomeric form and disassemble mature fibers suggests a mechanism by which PrP(C) might confer Aß toxicity in AD, as oligomers are thought to be the toxic form of Aß. Identification of a specific recognition site on PrP(C) that traps Aß in an oligomeric form is potentially a therapeutic target for the treatment of Alzheimer's disease.
Texto completo:
1
Base de dados:
MEDLINE
Assunto principal:
Peptídeos beta-Amiloides
/
Proteínas PrPC
/
Amiloide
Limite:
Animals
/
Humans
Idioma:
En
Ano de publicação:
2013
Tipo de documento:
Article